Xlife Sciences AG (XLS) — Cash Flow Quality Index
Latest as of December 2024:
-0.01x
Xlife Sciences AG (XLS) has a Cash Flow Quality Index of -0.01x as of December 2024. Operating cash flow of CHF-421.51K is below net income of CHF28.71 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Xlife Sciences AG cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.01x
Operating CF / Net Income
Operating Cash Flow
CHF-421.51K
CHF
Net Income
CHF28.71 Million
CHF
Data as of
Dec 2024
Most recent filing
Xlife Sciences AG Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Xlife Sciences AG across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see XLS cash generation efficiency.
Annual Cash Flow Quality Index for Xlife Sciences AG (2019–2024)
Year-by-year earnings quality comparison for Xlife Sciences AG.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.01x | CHF-421.51K | CHF34.28 Million | ▼ -206.5% |
| 2023 | 0.01x | CHF171.78K | CHF14.88 Million | ▲ +103.6% |
| 2022 | -0.32x | CHF-4.61 Million | CHF14.31 Million | ▼ -297.7% |
| 2021 | -0.08x | CHF-4.32 Million | CHF53.42 Million | ▼ -335.9% |
| 2020 | -0.02x | CHF-401.55K | CHF21.62 Million | ▲ +95.2% |
| 2019 | -0.39x | CHF-398.24K | CHF1.03 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.